Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation

Nature Communications

Volumn 7, Issue , 2016, Pages

  Li, Defang ^a,b   Liu, Jin ^a   Guo, Baosheng ^a,b   Liang, Chao ^a   Dang, Lei ^a   Lu, Cheng ^a,c   He, Xiaojuan ^a,c   Cheung, Hilda Yeuk Siu ^a   Xu, Liang ^a   Lu, Changwei ^a   He, Bing ^a   Liu, Biao ^a   Shaikh, Atik Badshah ^a   Li, Fangfei ^a   Wang, Luyao ^a   Yang, Zhijun ^a   Au, Doris Wai Ting ^d   Peng, Songlin ^a,e   Zhang, Zongkang ^f   Zhang, Bao Ting ^f   Pan, Xiaohua ^a,g   Qian, Airong ^a,h   Shang, Peng ^a,h   Xiao, Lianbo ^a,i   Jiang, Baohong ^j   Wong, Chris Kong Chu ^a   Xu, Jiake ^k   Bian, Zhaoxiang ^a   Liang, Zicai ^a   Guo, De An ^j   Zhu, Hailong ^a   Tan, Weihong ^a   Lu, Aiping ^a,b,c,i   Zhang, Ge ^a,b,i   more..

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b Kunshan Industrial Technology Research Institute   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^e SHENZHEN PEOPLE'S HOSPITAL   (China)

^f Prince of Wales Hospital   (Hong Kong)

^g SOUTHERN MEDICAL UNIVERSITY   (China)

^h NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

ⁱ Institute of Arthritis Research Shanghai Academy of Chinese Medical Sciences   (China)

^j SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; MICRORNA 214; MICRORNA; MIRN214 MICRORNA, HUMAN; MIRN214 MICRORNA, MOUSE;

BONE; INHIBITION; OSTEOLOGY; PROTEIN; RNA; RODENT; SERUM; SKELETON;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OVARIECTOMY; AGED; ANIMAL; BONE; BONE DEVELOPMENT; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; DOWN REGULATION; FRACTURE; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MIDDLE AGED; MOUSE; PATHOPHYSIOLOGY; VERY ELDERLY;

MUS;

AGED; AGED, 80 AND OVER; ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CASE-CONTROL STUDIES; CELLS, CULTURED; DOWN-REGULATION; EXOSOMES; FEMALE; FRACTURES, BONE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MIDDLE AGED; OSTEOCLASTS;

EID: 84960427882     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10872     Document Type: Article

References (47)

1. Sims, N. A. & Martin, T. J. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. BoneKEy Rep. 3, 481 (2014).
2. Rachner, T. D., Khosla, S. & Hofbauer, L. C. Osteoporosis: now and the future. Lancet 377, 1276-1287 (2011).
3. Zaidi, M. Skeletal remodeling in health and disease. Nature Med. 13, 791-801 (2007).
4. Martin, T. J. & Sims, N. A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11, 76-81 (2005).
5. Irie, N. et al. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J. Biol. Chem. 284, 14637-14644 (2009).
6. Negishi-Koga, T. et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nature Med. 17, 1473-1480 (2011).
7. Tang, Y. et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nature Med. 15, 757-765 (2009).
8. Rigoutsos, I. & Furnari, F. Gene-expression forum: decoy for microRNAs. Nature 465, 1016-1017 (2010).
9. Sun, K. & Lai, E. C. Adult-specific functions of animal microRNAs. Nat. Rev. Genet. 14, 535-548 (2013).
10. Kloosterman, W. P. & Plasterk, R. H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441-450 (2006).
11. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004).
12. Kosik, K. S. MicroRNAs and cellular phenotypy. Cell 143, 21-26 (2010).
13. Lian, J. B. et al. MicroRNA control of bone formation and homeostasis. Nat. Rev. Endocrinol. 8, 212-227 (2012).
14. van der Eerden, B. C. MicroRNAs in the skeleton: Cell-restricted or potent intercellular communicators? Arch. Biochem. Biophys. 561, 46-55 (2014).
15. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513-10518 (2008).
16. Cortez, M. A. & Calin, G. A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 9, 703-711 (2009).
17. Montecalvo, A. et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119, 756-766 (2012).
18. Hannafon, B. N. & Ding, W. Q. Intercellular communication by exosomederived microRNAs in cancer. Int. J. Mol. Sci. 14, 14240-14269 (2013).
19. Mittelbrunn, M. et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 (2011).
20. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
21. Li, K. et al. MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4. J. Biol. Chem. 290, 8185-8195 (2015).
22. Shi, K. et al. MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix. Bone 55, 487-494 (2013).
23. Wang, X. et al. miR-214 targets ATF4 to inhibit bone formation. Nature Med. 19, 93-100 (2013).
24. Zhao, C. et al. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol. 12, 343-353 (2015).
25. Inose, H. et al. A microRNA regulatory mechanism of osteoblast differentiation. Proc. Natl Acad. Sci. USA 106, 20794-20799 (2009).
26. Li, Z. et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl Acad. Sci. USA 105, 13906-13911 (2008).
27. Xu, J. F. et al. Altered microRNA expression profile in exosomes during osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. PLoS ONE 9, e114627 (2014).
28. Silverman, J. M. & Reiner, N. E. Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cell. Microbiol. 13, 1-9 (2011).
29. Gallo, A., Tandon, M., Alevizos, I. & Illei, G. G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7, e30679 (2012).
30. Koppers-Lalic, D. et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 8, 1649-1658 (2014).
31. Chia, L. Y., Walsh, N. C., Martin, T. J. & Sims, N. A. Isolation and gene expression of haematopoietic-cell-free preparations of highly purified murine osteocytes. Bone 72, 34-42 (2015).
32. Gu, G., Nars, M., Hentunen, T. A., Metsikko, K. & Vaananen, H. K. Isolated primary osteocytes express functional gap junctions in vitro. Cell. Tissue. Res. 323, 263-271 (2006).
33. Liang, C. et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nature Med. 21, 288-294 (2015).
34. Suetsugu, A. et al. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv. Drug Deliv. Rev. 65, 383-390 (2013).
35. Lotinun, S. et al. Osteoclast-specific cathepsin K deletion stimulates S1Pdependent bone formation. J. Clin. Invest. 123, 666-681 (2013).
36. Zhou, X. et al. Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc. Natl Acad. Sci. USA 107, 12919-12924 (2010).
37. Mause, S. F. & Weber, C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 107, 1047-1057 (2010).
38. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
39. van Balkom, B. W. et al. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 121, 3997-4006 S3991-3915 (2013).
40. Phan, T. C., Xu, J. & Zheng, M. H. Interaction between osteoblast and osteoclast: impact in bone disease. Histol. Histopathol. 19, 1325-1344 (2004).
41. Smalheiser, N. R. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol. Direct. 2, 35 (2007).
42. Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823 (2007).
43. Prokopi, M. et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114, 723-732 (2009).
44. Zhang, G. et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nature Med. 18, 307-314 (2012).
45. Liu, J. et al. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts. Biomaterials 52, 148-160 (2015).
46. Andela, V. B., Siddiqui, F., Groman, A. & Rosier, R. N. An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF kappa B in human osteosarcoma. J. Clin. Pathol. 58, 328-330 (2005).
47. Qin, L. et al. Staining intensity of individual osteons correlated with elastic properties and degrees of mineralization. J. Bone Miner. Metab. 19, 359-364 (2001).